25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

QTTB (Q32 Bio Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Q32 Bio Inc together

I guess you are interested in Q32 Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Q32 Bio Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Q32 Bio Inc’s Price Targets

I'm going to help you getting a better view of Q32 Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Q32 Bio Inc

I send you an email if I find something interesting about Q32 Bio Inc.

1. Quick Overview

1.1. Quick analysis of Q32 Bio Inc (30 sec.)










1.2. What can you expect buying and holding a share of Q32 Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-1.00
Expected worth in 1 year
$-4.75
How sure are you?
29.0%

+ What do you gain per year?

Total Gains per Share
$-3.75
Return On Investment
-196.4%

For what price can you sell your share?

Current Price per Share
$1.91
Expected price per share
$1.345 - $3.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Q32 Bio Inc (5 min.)




Live pricePrice per Share (EOD)
$1.91
Intrinsic Value Per Share
$24.09 - $31.91
Total Value Per Share
$23.08 - $30.91

2.2. Growth of Q32 Bio Inc (5 min.)




Is Q32 Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$12.2m-$295k$2.2m115.3%

How much money is Q32 Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$13m-$16.2m$3.1m24.3%
Net Profit Margin0.0%-415.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Q32 Bio Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Q32 Bio Inc?

Welcome investor! Q32 Bio Inc's management wants to use your money to grow the business. In return you get a share of Q32 Bio Inc.

First you should know what it really means to hold a share of Q32 Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Q32 Bio Inc is $1.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Q32 Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Q32 Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-1.00. Based on the TTM, the Book Value Change Per Share is $-0.94 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.76 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Q32 Bio Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.78-40.7%-1.07-56.1%-1.33-69.8%-1.70-89.1%-1.39-73.0%-1.54-80.8%
Usd Book Value Change Per Share-0.67-35.3%-0.94-49.1%-1.76-92.1%-1.73-90.3%-0.85-44.4%-0.03-1.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.67-35.3%-0.94-49.1%-1.76-92.1%-1.73-90.3%-0.85-44.4%-0.03-1.7%
Usd Price Per Share1.49-12.80-9.19-7.73-7.40-11.26-
Price to Earnings Ratio-0.48--2.35-11.76-3.10-0.31--0.82-
Price-to-Total Gains Ratio-2.21--10.85--5.74--5.69--2.33-7.73-
Price to Book Ratio-1.49-7.66-2.70-3.48-2.26-1.87-
Price-to-Total Gains Ratio-2.21--10.85--5.74--5.69--2.33-7.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.91
Number of shares523
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.94-0.85
Usd Total Gains Per Share-0.94-0.85
Gains per Quarter (523 shares)-490.37-443.65
Gains per Year (523 shares)-1,961.46-1,774.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1961-19710-1775-1785
20-3923-39320-3549-3560
30-5884-58930-5324-5335
40-7846-78540-7098-7110
50-9807-98150-8873-8885
60-11769-117760-10648-10660
70-13730-137370-12422-12435
80-15692-156980-14197-14210
90-17653-176590-15971-15985
100-19615-196200-17746-17760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%2.029.00.06.5%2.029.00.06.5%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%9.022.00.029.0%9.022.00.029.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%9.022.00.029.0%9.022.00.029.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Q32 Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.674-0.938+39%-1.760+161%-1.725+156%-0.848+26%-0.032-95%
Book Value Per Share---1.0030.158-734%-0.024-98%4.542-122%9.556-110%12.029-108%
Current Ratio--5.0575.316-5%4.619+9%5.852-14%7.895-36%10.393-51%
Debt To Asset Ratio--1.1851.000+19%1.520-22%0.919+29%0.623+90%0.481+146%
Debt To Equity Ratio---4.996-100%2.006-100%2.439-100%1.552-100%1.105-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---5345553.650144383541.775-104%43185089.200-112%105150836.658-105%160000679.195-103%245971751.363-102%
Eps---0.778-1.072+38%-1.333+71%-1.703+119%-1.394+79%-1.544+98%
Ev To Ebitda Ratio--0.147-1.498+1120%2.715-95%0.061+141%1.935-92%-0.524+456%
Free Cash Flow Per Share---0.959-1.131+18%-1.707+78%-1.644+71%-1.874+95%-1.779+85%
Free Cash Flow To Equity Per Share---0.985-1.111+13%0.216-555%-0.993+1%-1.053+7%-0.399-60%
Gross Profit Margin--1.0001.0000%1.036-3%1.064-6%1.039-4%1.025-2%
Intrinsic Value_10Y_max--31.914----------
Intrinsic Value_10Y_min--24.087----------
Intrinsic Value_1Y_max---5.167----------
Intrinsic Value_1Y_min---5.080----------
Intrinsic Value_3Y_max---9.150----------
Intrinsic Value_3Y_min---8.864----------
Intrinsic Value_5Y_max---5.447----------
Intrinsic Value_5Y_min---5.604----------
Market Cap23297416.000+22%18174446.350156129291.775-88%112120339.200-84%94280336.658-81%90227479.195-80%137357962.061-87%
Net Profit Margin----0%-4.1570%-19.7000%-15.6060%-24.5680%
Operating Margin----0%-3.2390%-18.1910%-22.7450%-29.1730%
Operating Ratio----0%3.116-100%18.483-100%23.029-100%29.907-100%
Pb Ratio-1.904-28%-1.4857.661-119%2.701-155%3.484-143%2.261-166%1.872-179%
Pe Ratio-0.614-28%-0.479-2.352+391%11.763-104%3.100-115%0.310-255%-0.816+70%
Price Per Share1.910+22%1.49012.800-88%9.192-84%7.729-81%7.397-80%11.261-87%
Price To Free Cash Flow Ratio-0.498-28%-0.388-2.165+458%-1.566+303%-1.291+233%-1.148+196%-1.668+330%
Price To Total Gains Ratio-2.834-28%-2.211-10.845+391%-5.737+160%-5.689+157%-2.327+5%7.730-129%
Quick Ratio--4.7545.071-6%6.021-21%7.876-40%9.922-52%14.931-68%
Return On Assets---0.144-0.151+5%-0.199+39%-0.169+18%-0.124-13%-0.111-23%
Return On Equity----0.8660%-0.1770%-0.4170%-0.2800%-0.2200%
Total Gains Per Share---0.674-0.938+39%-1.760+161%-1.725+156%-0.848+26%-0.032-95%
Usd Book Value---12235000.0001930250.000-734%-295000.000-98%55404500.000-122%116562050.000-110%146730386.839-108%
Usd Book Value Change Per Share---0.674-0.938+39%-1.760+161%-1.725+156%-0.848+26%-0.032-95%
Usd Book Value Per Share---1.0030.158-734%-0.024-98%4.542-122%9.556-110%12.029-108%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---5345553.650144383541.775-104%43185089.200-112%105150836.658-105%160000679.195-103%245971751.363-102%
Usd Eps---0.778-1.072+38%-1.333+71%-1.703+119%-1.394+79%-1.544+98%
Usd Free Cash Flow---11703000.000-13798750.000+18%-20824250.000+78%-20048250.000+71%-22856850.000+95%-21695867.419+85%
Usd Free Cash Flow Per Share---0.959-1.131+18%-1.707+78%-1.644+71%-1.874+95%-1.779+85%
Usd Free Cash Flow To Equity Per Share---0.985-1.111+13%0.216-555%-0.993+1%-1.053+7%-0.399-60%
Usd Market Cap23297416.000+22%18174446.350156129291.775-88%112120339.200-84%94280336.658-81%90227479.195-80%137357962.061-87%
Usd Price Per Share1.910+22%1.49012.800-88%9.192-84%7.729-81%7.397-80%11.261-87%
Usd Profit---9489000.000-13076000.000+38%-16255500.000+71%-20769583.333+119%-17000300.000+79%-18829468.355+98%
Usd Revenue----0%-3200750.0000%-836916.6670%1353950.000-100%1083354.774-100%
Usd Total Gains Per Share---0.674-0.938+39%-1.760+161%-1.725+156%-0.848+26%-0.032-95%
 EOD+6 -2MRQTTM+18 -13YOY+19 -143Y+20 -135Y+18 -1610Y+11 -23

3.3 Fundamental Score

Let's check the fundamental score of Q32 Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.614
Price to Book Ratio (EOD)Between0-1-1.904
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.754
Current Ratio (MRQ)Greater than15.057
Debt to Asset Ratio (MRQ)Less than11.185
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.144
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Q32 Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.415
Ma 20Greater thanMa 501.927
Ma 50Greater thanMa 1001.895
Ma 100Greater thanMa 2001.814
OpenGreater thanClose1.870
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Q32 Bio Inc

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.

Fundamental data was last updated by Penke on 2025-08-12 07:33:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Q32 Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Q32 Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-415.7%+415.7%
TTM-5Y-1,560.6%+1,560.6%
5Y-1,560.6%10Y-2,456.8%+896.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--95.1%+95.1%
TTM--142.2%+142.2%
YOY-415.7%-205.6%-210.1%
3Y-1,970.0%-257.3%-1,712.7%
5Y-1,560.6%-343.4%-1,217.2%
10Y-2,456.8%-503.2%-1,953.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Q32 Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • -14.4% Return on Assets means thatΒ Q32 Bio Inc generatedΒ $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Q32 Bio Inc:

  • The MRQ is -14.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.4%TTM-15.1%+0.8%
TTM-15.1%YOY-19.9%+4.8%
TTM-15.1%5Y-12.4%-2.7%
5Y-12.4%10Y-11.1%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.4%-11.6%-2.8%
TTM-15.1%-11.4%-3.7%
YOY-19.9%-11.3%-8.6%
3Y-16.9%-11.6%-5.3%
5Y-12.4%-11.8%-0.6%
10Y-11.1%-13.6%+2.5%
4.3.1.3. Return on Equity

Shows how efficient Q32 Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Q32 Bio Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Q32 Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-86.6%+86.6%
TTM-86.6%YOY-17.7%-68.9%
TTM-86.6%5Y-28.0%-58.6%
5Y-28.0%10Y-22.0%-5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.3%+13.3%
TTM-86.6%-14.5%-72.1%
YOY-17.7%-14.5%-3.2%
3Y-41.7%-16.5%-25.2%
5Y-28.0%-17.1%-10.9%
10Y-22.0%-19.2%-2.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Q32 Bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Q32 Bio Inc is operatingΒ .

  • Measures how much profit Q32 Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Q32 Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-323.9%+323.9%
TTM-5Y-2,274.5%+2,274.5%
5Y-2,274.5%10Y-2,917.3%+642.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--190.4%+190.4%
TTM--234.1%+234.1%
YOY-323.9%-212.3%-111.6%
3Y-1,819.1%-240.5%-1,578.6%
5Y-2,274.5%-348.6%-1,925.9%
10Y-2,917.3%-488.3%-2,429.0%
4.3.2.2. Operating Ratio

Measures how efficient Q32 Bio Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Q32 Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.116-3.116
TTM-5Y23.029-23.029
5Y23.02910Y29.907-6.877
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.026-2.026
TTM-2.666-2.666
YOY3.1163.011+0.105
3Y18.4833.512+14.971
5Y23.0294.642+18.387
10Y29.9076.651+23.256
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Q32 Bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Q32 Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 5.06Β means the company has $5.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Q32 Bio Inc:

  • The MRQ is 5.057. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.316. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.057TTM5.316-0.260
TTM5.316YOY4.619+0.697
TTM5.3165Y7.895-2.579
5Y7.89510Y10.393-2.498
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0573.543+1.514
TTM5.3163.775+1.541
YOY4.6194.140+0.479
3Y5.8524.680+1.172
5Y7.8955.742+2.153
10Y10.3936.175+4.218
4.4.3.2. Quick Ratio

Measures if Q32 Bio Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 4.75Β means the company can pay off $4.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Q32 Bio Inc:

  • The MRQ is 4.754. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.071. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.754TTM5.071-0.317
TTM5.071YOY6.021-0.950
TTM5.0715Y9.922-4.851
5Y9.92210Y14.931-5.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7543.128+1.626
TTM5.0713.433+1.638
YOY6.0213.928+2.093
3Y7.8764.516+3.360
5Y9.9225.876+4.046
10Y14.9316.523+8.408
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Q32 Bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Q32 Bio IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Q32 Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.19Β means that Q32 Bio Inc assets areΒ financed with 118.5% credit (debt) and the remaining percentage (100% - 118.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Q32 Bio Inc:

  • The MRQ is 1.185. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.000. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.185TTM1.000+0.185
TTM1.000YOY1.520-0.520
TTM1.0005Y0.623+0.377
5Y0.62310Y0.481+0.142
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1850.342+0.843
TTM1.0000.356+0.644
YOY1.5200.332+1.188
3Y0.9190.340+0.579
5Y0.6230.350+0.273
10Y0.4810.378+0.103
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Q32 Bio Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Q32 Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.996-4.996
TTM4.996YOY2.006+2.990
TTM4.9965Y1.552+3.444
5Y1.55210Y1.105+0.447
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.390-0.390
TTM4.9960.440+4.556
YOY2.0060.419+1.587
3Y2.4390.455+1.984
5Y1.5520.464+1.088
10Y1.1050.511+0.594
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Q32 Bio Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Q32 Bio Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.48 means the investor is paying $-0.48Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Q32 Bio Inc:

  • The EOD is -0.614. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.479. Based on the earnings, the company is expensive. -2
  • The TTM is -2.352. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.614MRQ-0.479-0.135
MRQ-0.479TTM-2.352+1.873
TTM-2.352YOY11.763-14.114
TTM-2.3525Y0.310-2.662
5Y0.31010Y-0.816+1.126
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.614-2.518+1.904
MRQ-0.479-2.092+1.613
TTM-2.352-2.752+0.400
YOY11.763-3.911+15.674
3Y3.100-3.875+6.975
5Y0.310-6.363+6.673
10Y-0.816-6.876+6.060
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Q32 Bio Inc:

  • The EOD is -0.498. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.165. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.498MRQ-0.388-0.109
MRQ-0.388TTM-2.165+1.776
TTM-2.165YOY-1.566-0.599
TTM-2.1655Y-1.148-1.017
5Y-1.14810Y-1.668+0.520
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.498-3.678+3.180
MRQ-0.388-2.839+2.451
TTM-2.165-3.941+1.776
YOY-1.566-4.426+2.860
3Y-1.291-5.256+3.965
5Y-1.148-8.609+7.461
10Y-1.668-9.357+7.689
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Q32 Bio Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -1.49 means the investor is paying $-1.49Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Q32 Bio Inc:

  • The EOD is -1.904. Based on the equity, the company is expensive. -2
  • The MRQ is -1.485. Based on the equity, the company is expensive. -2
  • The TTM is 7.661. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-1.904MRQ-1.485-0.419
MRQ-1.485TTM7.661-9.146
TTM7.661YOY2.701+4.959
TTM7.6615Y2.261+5.400
5Y2.26110Y1.872+0.390
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.9042.321-4.225
MRQ-1.4851.909-3.394
TTM7.6612.210+5.451
YOY2.7012.525+0.176
3Y3.4842.530+0.954
5Y2.2613.728-1.467
10Y1.8724.400-2.528
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Q32 Bio Inc.

4.8.3. Insider Transactions

Insiders are holding 6.566% of the shares of Q32 Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-25Paul AllowaySELL26824.21
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Total Other Income Expense Net 2,390-1,1711,219-8613588391,197-1,515-318



5.2. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets66,117
Total Liabilities78,352
Total Stockholder Equity-12,235
 As reported
Total Liabilities 78,352
Total Stockholder Equity+ -12,235
Total Assets = 66,117

Assets

Total Assets66,117
Total Current Assets58,324
Long-term Assets7,793
Total Current Assets
Cash And Cash Equivalents 54,832
Other Current Assets 3,492
Total Current Assets  (as reported)58,324
Total Current Assets  (calculated)58,324
+/-0
Long-term Assets
Property Plant Equipment 6,576
Long-term Assets Other 570
Long-term Assets  (as reported)7,793
Long-term Assets  (calculated)7,146
+/- 647

Liabilities & Shareholders' Equity

Total Current Liabilities11,534
Long-term Liabilities66,818
Total Stockholder Equity-12,235
Total Current Liabilities
Short-term Debt 6,879
Short Long Term Debt 6,228
Accounts payable 910
Other Current Liabilities 3,745
Total Current Liabilities  (as reported)11,534
Total Current Liabilities  (calculated)17,762
+/- 6,228
Long-term Liabilities
Long term Debt 6,522
Capital Lease Obligations 5,947
Long-term Liabilities Other 55,000
Long-term Liabilities  (as reported)66,818
Long-term Liabilities  (calculated)67,469
+/- 651
Total Stockholder Equity
Common Stock2
Retained Earnings -255,334
Other Stockholders Equity 243,097
Total Stockholder Equity (as reported)-12,235
Total Stockholder Equity (calculated)-12,235
+/-0
Other
Capital Stock2
Cash and Short Term Investments 54,832
Common Stock Shares Outstanding 12,198
Liabilities and Stockholders Equity 66,117
Net Debt -36,135
Net Invested Capital 515
Net Working Capital 46,790
Property Plant and Equipment Gross 8,239
Short Long Term Debt Total 18,697



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
0
137,530
129,078
270,315
268,397
259,094
233,026
341,156
316,759
310,567
288,788
258,238
228,362
263,737
234,697
258,918
230,816
211,721
310,958
284,609
262,651
228,470
197,881
169,337
53,769
306,119
152,334
124,207
104,542
92,332
79,071
66,117
66,11779,07192,332104,542124,207152,334306,11953,769169,337197,881228,470262,651284,609310,958211,721230,816258,918234,697263,737228,362258,238288,788310,567316,759341,156233,026259,094268,397270,315129,078137,5300
   > Total Current Assets 
0
131,603
120,405
261,582
245,866
221,685
190,502
298,769
274,079
266,577
238,333
209,807
181,255
219,564
191,652
217,937
191,817
191,909
262,448
238,440
213,204
181,015
153,583
131,336
39,101
83,914
138,043
111,620
93,898
81,877
68,632
58,324
58,32468,63281,87793,898111,620138,04383,91439,101131,336153,583181,015213,204238,440262,448191,909191,817217,937191,652219,564181,255209,807238,333266,577274,079298,769190,502221,685245,866261,582120,405131,6030
       Cash And Cash Equivalents 
0
51,575
46,213
94,961
36,038
38,220
40,839
115,566
77,559
53,774
143,372
167,636
178,003
217,431
104,416
116,313
95,829
108,382
248,127
176,188
43,162
33,986
39,454
76,797
36,256
39,266
115,509
97,661
89,078
77,965
65,483
54,832
54,83265,48377,96589,07897,661115,50939,26636,25676,79739,45433,98643,162176,188248,127108,38295,829116,313104,416217,431178,003167,636143,37253,77477,559115,56640,83938,22036,03894,96146,21351,5750
       Short-term Investments 
0
78,084
70,519
160,548
201,506
176,517
147,128
180,230
192,113
208,614
91,557
39,007
0
0
84,233
96,980
91,722
47,491
7,999
49,335
157,912
141,040
110,571
50,274
74,187
43,387
19,803
9,986
0
0
0
0
00009,98619,80343,38774,18750,274110,571141,040157,91249,3357,99947,49191,72296,98084,2330039,00791,557208,614192,113180,230147,128176,517201,506160,54870,51978,0840
       Net Receivables 
0
0
0
0
0
0
0
0
300
400
400
400
400
400
300
200
100
0
0
0
1,064
1,064
0
680
680
563
563
563
563
555
555
0
055555556356356356368068001,0641,06400010020030040040040040040030000000000
       Other Current Assets 
0
1,945
3,672
6,074
8,322
6,948
2,535
2,973
4,107
3,789
3,004
2,764
2,852
1,733
2,703
4,444
4,166
36,036
6,322
12,917
12,130
1,896
3,558
4,265
2,165
1,261
2,168
3,410
4,257
3,357
2,594
3,492
3,4922,5943,3574,2573,4102,1681,2612,1654,2653,5581,89612,13012,9176,32236,0364,1664,4442,7031,7332,8522,7643,0043,7894,1072,9732,5356,9488,3226,0743,6721,9450
   > Long-term Assets 
0
5,927
8,673
8,732
22,530
37,409
42,524
42,387
42,680
43,990
50,455
48,431
47,107
44,173
43,045
40,981
38,999
19,812
48,510
46,169
49,447
47,455
44,298
38,001
14,668
222,205
14,291
12,587
10,644
10,455
10,439
7,793
7,79310,43910,45510,64412,58714,291222,20514,66838,00144,29847,45549,44746,16948,51019,81238,99940,98143,04544,17347,10748,43150,45543,99042,68042,38742,52437,40922,5308,7328,6735,9270
       Property Plant Equipment 
0
3,154
3,828
6,942
20,741
35,637
40,984
41,113
41,406
42,716
49,181
47,157
45,833
42,899
41,771
39,707
37,725
17,859
17,595
16,871
22,315
21,641
21,262
20,682
8,344
650
7,819
7,569
7,357
7,092
6,822
6,576
6,5766,8227,0927,3577,5697,8196508,34420,68221,26221,64122,31516,87117,59517,85937,72539,70741,77142,89945,83347,15749,18142,71641,40641,11340,98435,63720,7416,9423,8283,1540
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,724
4,724
3,275
2,600
2,600
2,526
0
02,5262,6002,6003,2754,7244,7240000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000
> Total Liabilities 
0
39,222
40,841
43,516
55,637
64,377
58,762
56,414
58,937
52,060
62,247
63,534
58,140
67,742
33,868
34,341
32,245
42,070
44,704
44,321
53,590
50,492
45,982
49,962
210,220
233,128
103,565
90,696
86,247
86,657
83,085
78,352
78,35283,08586,65786,24790,696103,565233,128210,22049,96245,98250,49253,59044,32144,70442,07032,24534,34133,86867,74258,14063,53462,24752,06058,93756,41458,76264,37755,63743,51640,84139,2220
   > Total Current Liabilities 
0
8,862
9,442
10,876
18,574
25,433
17,647
15,491
18,682
12,374
17,452
19,564
17,178
22,658
17,808
19,534
18,705
17,226
20,802
20,734
25,252
22,576
18,507
22,939
71,838
11,573
32,953
17,194
14,383
16,465
14,579
11,534
11,53414,57916,46514,38317,19432,95311,57371,83822,93918,50722,57625,25220,73420,80217,22618,70519,53417,80822,65817,17819,56417,45212,37418,68215,49117,64725,43318,57410,8769,4428,8620
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
2,331
2,413
2,497
2,501
2,323
2,142
1,959
246
435
410
1,489
32,873
1,626
1,701
38,333
1,318
4,648
1,351
2,560
3,709
5,293
6,879
6,8795,2933,7092,5601,3514,6481,31838,3331,7011,62632,8731,4894104352461,9592,1422,3232,5012,4972,4132,3310000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,402
32,402
0
37,812
37,812
3,088
3,088
0
1,533
3,097
4,662
6,228
6,2284,6623,0971,53303,0883,08837,81237,812032,40232,40200000000000000000000
       Accounts payable 
0
2,538
3,776
5,017
11,121
15,732
11,794
8,334
8,798
2,608
7,398
7,103
3,316
4,722
4,878
5,696
3,522
2,366
9,885
3,762
4,835
1,435
3,635
3,393
1,829
3,234
4,960
2,484
1,258
2,989
2,712
910
9102,7122,9891,2582,4844,9603,2341,8293,3933,6351,4354,8353,7629,8852,3663,5225,6964,8784,7223,3167,1037,3982,6088,7988,33411,79415,73211,1215,0173,7762,5380
       Other Current Liabilities 
0
2,983
2,258
2,358
3,848
6,017
4,948
6,467
9,110
8,957
6,949
9,274
8,426
9,803
5,423
7,689
10,016
11,406
6,307
12,940
16,154
8,456
12,892
17,845
6,813
7,021
23,029
13,323
10,529
9,767
6,574
3,745
3,7456,5749,76710,52913,32323,0297,0216,81317,84512,8928,45616,15412,9406,30711,40610,0167,6895,4239,8038,4269,2746,9498,9579,1106,4674,9486,0173,8482,3582,2582,9830
   > Long-term Liabilities 
0
30,360
31,399
32,641
37,063
38,944
41,115
40,923
40,255
39,686
44,795
43,970
40,962
45,084
16,060
14,807
13,540
24,844
23,902
23,587
28,338
27,916
27,475
27,023
138,382
221,555
70,612
73,502
71,864
70,192
68,506
66,818
66,81868,50670,19271,86473,50270,612221,555138,38227,02327,47527,91628,33823,58723,90224,84413,54014,80716,06045,08440,96243,97044,79539,68640,25540,92341,11538,94437,06332,64131,39930,3600
> Total Stockholder Equity
0
98,308
88,237
226,798
212,760
194,717
174,264
284,742
257,822
258,507
226,541
194,704
170,222
195,995
200,829
224,577
198,571
169,651
266,254
240,288
209,061
177,978
151,899
119,375
-156,451
72,991
48,769
33,511
18,295
5,675
-4,014
-12,235
-12,235-4,0145,67518,29533,51148,76972,991-156,451119,375151,899177,978209,061240,288266,254169,651198,571224,577200,829195,995170,222194,704226,541258,507257,822284,742174,264194,717212,760226,79888,23798,3080
   Common Stock
0
1
0
4
4
3
3
4
4
4
4
4
4
5
5
6
6
6
6
6
6
6
6
6
1
6
2
2
2
2
2
2
22222261666666666554444443344010
   Retained Earnings Total Equity00000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-73
-86
-49
-21
-77
6
186
254
183
-19
11
0
0
-23
2
-5
-7
-41
-41
-457
-404
-182
-88
-36
-5
-5
-1
-1
0
0
0
000-1-1-5-5-36-88-182-404-457-41-41-7-52-230011-191832541866-77-21-49-86-730
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
799
1,265
290,442
291,172
292,187
293,865
430,432
433,071
457,994
461,561
465,034
468,795
524,358
530,288
584,510
589,119
593,784
598,275
601,439
604,354
1,100,956
610,056
612,482
1,336,261
615,088
234,824
236,540
238,919
240,487
241,829
243,097
243,097241,829240,487238,919236,540234,824615,0881,336,261612,482610,0561,100,956604,354601,439598,275593,784589,119584,510530,288524,358468,795465,034461,561457,994433,071430,432293,865292,187291,172290,4421,2657990



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-487
Gross Profit-487-487
 
Operating Income (+$)
Gross Profit-487
Operating Expense-65,615
Operating Income-66,102-66,102
 
Operating Expense (+$)
Research Development48,143
Selling General Administrative17,959
Selling And Marketing Expenses0
Operating Expense65,61566,102
 
Net Interest Income (+$)
Interest Income3,900
Interest Expense-300
Other Finance Cost-800
Net Interest Income2,800
 
Pretax Income (+$)
Operating Income-66,102
Net Interest Income2,800
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-46,087-86,117
EBIT - interestExpense = -46,087
-47,712
-47,433
Interest Expense300
Earnings Before Interest and Taxes (EBIT)-45,787-45,787
Earnings Before Interest and Taxes (EBITDA)-45,300
 
After tax Income (+$)
Income Before Tax-46,087
Tax Provision-21
Net Income From Continuing Ops-47,733-46,108
Net Income-47,733
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses66,102
Total Other Income/Expenses Net20,015-2,800
 

Technical Analysis of Q32 Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Q32 Bio Inc. The general trend of Q32 Bio Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Q32 Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Q32 Bio Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Q32 Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.9 < 3.58 < 3.75.

The bearish price targets are: 1.5685 > 1.345.

Know someone who trades $QTTB? Share this with them.πŸ‘‡

Q32 Bio Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Q32 Bio Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Q32 Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Q32 Bio Inc. The current macd is -0.03258608.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Q32 Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Q32 Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Q32 Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Q32 Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartQ32 Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Q32 Bio Inc. The current adx is 18.08.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Q32 Bio Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Q32 Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Q32 Bio Inc. The current sar is 1.5685.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Q32 Bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Q32 Bio Inc. The current rsi is 49.41. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Q32 Bio Inc Daily Relative Strength Index (RSI) ChartQ32 Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Q32 Bio Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Q32 Bio Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Q32 Bio Inc Daily Stochastic Oscillator ChartQ32 Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Q32 Bio Inc. The current cci is -18.4149874.

Q32 Bio Inc Daily Commodity Channel Index (CCI) ChartQ32 Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Q32 Bio Inc. The current cmo is -0.26067259.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Q32 Bio Inc Daily Chande Momentum Oscillator (CMO) ChartQ32 Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Q32 Bio Inc. The current willr is -35.74788335.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Q32 Bio Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Q32 Bio Inc Daily Williams %R ChartQ32 Bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Q32 Bio Inc.

Q32 Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Q32 Bio Inc. The current atr is 0.22427518.

Q32 Bio Inc Daily Average True Range (ATR) ChartQ32 Bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Q32 Bio Inc. The current obv is 45,421,653.

Q32 Bio Inc Daily On-Balance Volume (OBV) ChartQ32 Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Q32 Bio Inc. The current mfi is 48.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Q32 Bio Inc Daily Money Flow Index (MFI) ChartQ32 Bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Q32 Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Q32 Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Q32 Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.415
Ma 20Greater thanMa 501.927
Ma 50Greater thanMa 1001.895
Ma 100Greater thanMa 2001.814
OpenGreater thanClose1.870
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Q32 Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Q32 Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Q32 Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Q32 Bio Inc

I send you an email if I find something interesting about Q32 Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Q32 Bio Inc.

Receive notifications about Q32 Bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.